Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Jun;5(6):657-67.

Epothilone D (Kosan/Roche)

Affiliations
  • PMID: 15242255
Review

Epothilone D (Kosan/Roche)

Ada Kolman. Curr Opin Investig Drugs. 2004 Jun.

Abstract

Kosan and Roche are developing the microtubule inhibitor epothilone D (KOS-862 and NSC-703147), an analog of epothilone B for the potential treatment of cancer. Phase II trials in colorectal, metastatic breast and non-small-cell lung cancers were initiated in December 2003.

PubMed Disclaimer

Similar articles

  • BMS-247550 Bristol-Myers Squibb/GBF.
    Lin N, Brakora K, Seiden M. Lin N, et al. Curr Opin Investig Drugs. 2003 Jun;4(6):746-56. Curr Opin Investig Drugs. 2003. PMID: 12901236 Review.
  • BMS-310705 Bristol-Myers Squibb/GBF.
    Kolman A. Kolman A. Curr Opin Investig Drugs. 2004 Dec;5(12):1292-7. Curr Opin Investig Drugs. 2004. PMID: 15648951 Review.
  • EPO-906 (Novartis).
    Galmarini CM, Dumontet C. Galmarini CM, et al. IDrugs. 2003 Dec;6(12):1182-7. IDrugs. 2003. PMID: 14666430 Review.
  • OSI-461 (OSI).
    Galmarini CM. Galmarini CM. Curr Opin Investig Drugs. 2004 Jun;5(6):648-56. Curr Opin Investig Drugs. 2004. PMID: 15242254 Review.
  • MS-209 Schering.
    Robert J. Robert J. Curr Opin Investig Drugs. 2004 Dec;5(12):1340-7. Curr Opin Investig Drugs. 2004. PMID: 15648956 Review.

Cited by

MeSH terms

LinkOut - more resources